SG49813A1 - Benzopyran and related ltb antagonists - Google Patents

Benzopyran and related ltb antagonists

Info

Publication number
SG49813A1
SG49813A1 SG1996006699A SG1996006699A SG49813A1 SG 49813 A1 SG49813 A1 SG 49813A1 SG 1996006699 A SG1996006699 A SG 1996006699A SG 1996006699 A SG1996006699 A SG 1996006699A SG 49813 A1 SG49813 A1 SG 49813A1
Authority
SG
Singapore
Prior art keywords
benzopyran
ltb
antagonists
ltb antagonists
related ltb
Prior art date
Application number
SG1996006699A
Other languages
English (en)
Inventor
Kevin Koch
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SG49813A1 publication Critical patent/SG49813A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
SG1996006699A 1992-01-23 1992-11-13 Benzopyran and related ltb antagonists SG49813A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82441292A 1992-01-23 1992-01-23

Publications (1)

Publication Number Publication Date
SG49813A1 true SG49813A1 (en) 1998-06-15

Family

ID=25241346

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996006699A SG49813A1 (en) 1992-01-23 1992-11-13 Benzopyran and related ltb antagonists

Country Status (37)

Country Link
US (2) US5552435A (zh)
EP (1) EP0623123B1 (zh)
JP (1) JP2765757B2 (zh)
KR (2) KR0124802B1 (zh)
CN (1) CN1041311C (zh)
AP (1) AP352A (zh)
AT (1) ATE152108T1 (zh)
AU (1) AU666896B2 (zh)
BG (1) BG62331B1 (zh)
BR (1) BR9207061A (zh)
CA (1) CA2126752C (zh)
CZ (1) CZ282400B6 (zh)
DE (1) DE69219364T2 (zh)
DK (1) DK0623123T3 (zh)
EG (1) EG20202A (zh)
FI (1) FI943474A (zh)
GR (1) GR3023657T3 (zh)
HK (1) HK1000245A1 (zh)
HU (1) HU221194B1 (zh)
IL (1) IL104386A (zh)
IS (1) IS1795B (zh)
MX (1) MX9300312A (zh)
MY (1) MY109144A (zh)
NO (1) NO306508B1 (zh)
NZ (1) NZ245735A (zh)
OA (1) OA11456A (zh)
PH (1) PH30346A (zh)
PL (1) PL171003B1 (zh)
PT (1) PT101183B (zh)
RO (1) RO112031B1 (zh)
RU (1) RU2114110C1 (zh)
SG (1) SG49813A1 (zh)
SK (1) SK280451B6 (zh)
TW (1) TW213907B (zh)
WO (1) WO1993015067A1 (zh)
YU (1) YU48949B (zh)
ZA (1) ZA93486B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2084547B1 (es) * 1993-07-12 1997-01-16 Pfizer Antagonistas benzopiranicos y relacionados de leucotrieno b4.
MX9702731A (es) * 1994-10-13 1997-06-28 Pfizer Compuestos de benzopirano y benzo fusionados, composiciones que los contienen y uso de los mismos.
CA2202056A1 (en) * 1994-10-13 1996-04-25 Mark A. Dombroski Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists
SK31399A3 (en) * 1996-09-16 2000-05-16 Pfizer Processes and intermediates for preparing substituted chromanol derivatives
US6416733B1 (en) 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
EP0836850A3 (en) * 1996-10-17 2000-11-29 Pfizer Inc. Method of preventing allograft rejection
EP0963755A3 (en) * 1998-04-16 2001-03-14 Pfizer Products Inc. Use of benzopyranes for preventing allograft rejection
US6436987B1 (en) * 2000-06-08 2002-08-20 Pfizer Inc. Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid
JP2004512382A (ja) 2000-11-03 2004-04-22 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー 心臓灌流および心臓炎症の2核種同時イメージング
CA2433516A1 (en) * 2001-01-30 2002-08-08 Keith Michael Devries Processes for preparing chromanylbenzoic acids
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
CA2574627A1 (en) * 2004-07-22 2006-02-02 Pharmacia Corporation Compositions for treatment of inflammation and pain using a combination of a cox-2 selective inhibitor and a ltb4 receptor antagonist
EP3383389B1 (en) * 2015-11-30 2021-04-28 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as blt1 antagonists
US20190382363A1 (en) 2015-11-30 2019-12-19 Merck Sharp & Dohme Corp. Aryl sulfonamides as blt1 antagonists
US10336733B2 (en) 2015-11-30 2019-07-02 Merk Sharp & Dohme Corp. Aryl acylsulfonamides as BLT1 antagonists
US10450309B2 (en) 2015-11-30 2019-10-22 Merch Sharp & Dohme Corp. Aryl sulfonamides as BLT1 antagonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2309282A1 (de) * 1973-02-24 1974-08-29 Hoechst Ag Verfahren zur herstellung von 4-hydroxy-thiochromanen
DE2745305A1 (de) * 1977-10-07 1979-04-19 Bayer Ag Insektizide und akarizide mittel
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
CA1320490C (en) * 1987-01-12 1993-07-20 Darrel M. Gapinski Anti-inflammatory agents
JPS63292977A (ja) * 1987-05-25 1988-11-30 片山 晋 スキ−用のビンディング固定板
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
MX13485A (es) * 1987-10-19 1993-05-01 Pfizer Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos
WO1990012010A1 (en) * 1989-04-07 1990-10-18 Pfizer Inc. Substituted chromans in the treatment of asthma, arthritis and related diseases
WO1990015801A1 (en) * 1989-06-22 1990-12-27 Pfizer Inc. Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases
WO1991012253A1 (en) * 1990-02-07 1991-08-22 Pfizer Inc. Tetralin and chroman derivatives useful in the treatment of asthma, arthritis, and related diseases
WO1993015066A1 (en) * 1992-01-23 1993-08-05 Pfizer Inc. Benzopyran and related ltb4 antagonists
HRP930210A2 (en) * 1992-02-25 1995-06-30 Recordati Chem Pharm Heterobicyclic compounds and pharmaceutical preparations containing them
FR2693196B1 (fr) * 1992-07-03 1994-12-23 Lipha Dérivés de benzopyranone ou de benzothiopyranone, procédé de préparation et composition pharmaceutique les contenant.

Also Published As

Publication number Publication date
GR3023657T3 (en) 1997-09-30
YU3393A (sh) 1996-07-24
CZ176294A3 (en) 1995-02-15
FI943474A0 (fi) 1994-07-22
HK1000245A1 (en) 1998-02-13
PT101183A (pt) 1994-03-31
SK280451B6 (sk) 2000-02-14
OA11456A (en) 2003-11-18
NO306508B1 (no) 1999-11-15
US5552435A (en) 1996-09-03
IS1795B (is) 2001-12-18
IL104386A (en) 2001-05-20
NO942759L (no) 1994-07-22
BG62331B1 (bg) 1999-08-31
BG98867A (bg) 1995-03-31
JP2765757B2 (ja) 1998-06-18
SK84494A3 (en) 1995-05-10
PT101183B (pt) 1999-09-30
EP0623123A1 (en) 1994-11-09
WO1993015067A1 (en) 1993-08-05
IL104386A0 (en) 1993-05-13
AP352A (en) 1994-08-10
CA2126752A1 (en) 1993-08-05
CA2126752C (en) 2000-05-16
KR950700273A (ko) 1995-01-16
US5684046A (en) 1997-11-04
DE69219364T2 (de) 1997-08-07
NZ245735A (en) 1995-04-27
BR9207061A (pt) 1995-12-26
MY109144A (en) 1996-12-31
EG20202A (en) 1997-10-30
TW213907B (zh) 1993-10-01
CZ282400B6 (cs) 1997-07-16
JPH07502536A (ja) 1995-03-16
NO942759D0 (no) 1994-07-22
ZA93486B (en) 1994-07-22
DE69219364D1 (de) 1997-05-28
HUT68790A (en) 1995-07-28
RU2114110C1 (ru) 1998-06-27
RU94035964A (ru) 1997-05-27
MX9300312A (es) 1993-07-31
DK0623123T3 (da) 1997-10-13
HU9401979D0 (en) 1994-09-28
FI943474A (fi) 1994-07-22
CN1041311C (zh) 1998-12-23
YU48949B (sh) 2003-01-31
EP0623123B1 (en) 1997-04-23
AU3065092A (en) 1993-09-01
RO112031B1 (ro) 1997-04-30
AP9200449A0 (en) 1993-01-31
KR0124802B1 (ko) 1997-11-25
HU221194B1 (en) 2002-08-28
PH30346A (en) 1997-04-02
IS3969A (is) 1993-07-24
PL171003B1 (pl) 1997-02-28
ATE152108T1 (de) 1997-05-15
CN1075318A (zh) 1993-08-18
AU666896B2 (en) 1996-02-29

Similar Documents

Publication Publication Date Title
HU9600932D0 (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
GR3022999T3 (en) Benzopyran and related ltb 4? antagonists.
GB9204769D0 (en) Workcentre and supports
SG49813A1 (en) Benzopyran and related ltb antagonists
GB9318271D0 (en) Tocopherols
IL115528A0 (en) Benzopyran and benzo-fused compounds
GB9204770D0 (en) Workcentre and supports
HU9303442D0 (en) Jodinated benzoyl-acetats and ketals
ZA93582B (en) Substituted hexahyhdroazephinones and tetrahydrobenzazepinones
ZA93483B (en) Benzopyrans and related ltb antagonists
PL309361A1 (en) Benzopyran derivatives
EP0505941A3 (en) Peptifluorin and neopeptifluorin
AU117796S (en) Railing
ZA899435B (en) Benzopyran and related compounds
IE901744L (en) Benzopyran and pyridopyran derivatives
IL122653A0 (en) Benzopyrans and their preparation
GB9110191D0 (en) Sled-platform and piston
ZA947921B (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
PL296873A1 (en) Substituted and heterocyclic phtalides
ZA941635B (en) Benzopyrans
GB9324403D0 (en) Benzodioxanylimidazoline and benzodioxanylimidazole derivatives
GB9300568D0 (en) Benzodioxanylimidazoline and benzodioxanylimidazole derivatives
GB9200111D0 (en) Personal comfypad
GB9118954D0 (en) Construction components and their uses
ZA925260B (en) 3-aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone